As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Hengrui Pharmaceuticals Co. Ltd. is out-licensing to GSK plc its potential best-in-class phase I phosphodiesterase 3 and 4 inhibitor (HRS-9821) for treating chronic obstructive pulmonary disease along ...

Today's Gold Rate in Faridabad: Check for gold price in Faridabad today and the last 10 days of gold rate in Faridabad for 18, 22 and 24 carat based on 1gm, 8gm, 10gm, and 100 gm on ...

A table showing all the new US tariffs announced by President Trump on Friday ...

(SMP) on Tuesday reported second-quarter profit of $25.2 million. On a per-share basis, the Long Island City, New York-based company said it had profit of $1.13. Earnings, adjusted for one-time gains ...

After-Hours Center Recent News NuScale Power Stock Slides After Q2 Earnings Report: Here's Why Here's a look at NuScale Power's Q2 report.